Skip to main content
NCBI home page
Archives of Disease in Childhood logoLink to Archives of Disease in Childhood
. 1984 Apr;59(4):360–365. doi: 10.1136/adc.59.4.360

Plasma renin activity in the management of congenital adrenal hyperplasia.

K D Griffiths, J M Anderson, B T Rudd, N K Virdi, G Holder, P H Rayner
PMCID: PMC1628693  PMID: 6372706

Abstract

Fourteen children with salt losing and five children with non-salt losing congenital adrenal hyperplasia were studied. Venous samples were collected for measurement of plasma renin activity, serum 17 alpha-hydroxyprogesterone, testosterone, sodium, and creatinine. Overnight urinary sodium and creatinine excretions were measured after collection on an outpatient basis. Eight 'salt losers' had a raised plasma renin activity despite mineralocorticoid treatment, as did one 'non-salt loser'. Six of the children in whom clinical and biochemical control was inadequate, including the 'non-salt loser', had an increase in the dose of fludrocortisone. When the investigations were repeated one month later, a fall in plasma renin activity accompanied by a fall in 17 alpha-hydroxyprogesterone in all but one patient were found. The dose of mineralocorticoid may be as critical as the dose of glucocorticoid in the management of congenital adrenal hyperplasia, and regular determination of plasma renin activity should be made, particularly if clinical control is difficult.

Full text

PDF
360

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Atherden S. M., Barnes N. D., Grant D. B. Circadian variation in plasma 17-hydroxyprogesterone in patients with congenital adrenal hyperplasia. Arch Dis Child. 1972 Aug;47(254):602–604. doi: 10.1136/adc.47.254.602. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Broughton Pipkin F., Smales O. R., O'Callaghan M. Renin and angiotensin levels in children. Arch Dis Child. 1981 Apr;56(4):298–302. doi: 10.1136/adc.56.4.298. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. CARA J., GARDNER L. I. THE JUXTAGLOMERULAR CELLS OF THE KIDNEY AND THE ZONA GLOMERULOSA OF THE ADRENAL CORTEX IN THE SODIUM-LOSING AND THE HYPERTENSIVE FORMS OF VIRILIZING ADRENAL HYPERPLASIA. Pediatrics. 1963 Nov;32:825–840. [PubMed] [Google Scholar]
  4. Davila N., Rudd B. T., Morris R., Kandeel F., Bodden J., London D. R. A simple procedure for the radioimmunoassay of 17 alpha-hydroxyprogesterone in serum: comparison with an immunological purification technique. Ann Clin Biochem. 1980 Jan;17(1):31–37. doi: 10.1177/000456328001700106. [DOI] [PubMed] [Google Scholar]
  5. Frisch H., Parth K., Schober E., Swoboda W. Circadian patterns of plasma cortisol, 17-hydroxyprogesterone, and testosterone in congenital adrenal hyperplasia. Arch Dis Child. 1981 Mar;56(3):208–213. doi: 10.1136/adc.56.3.208. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Grant D. B., Dillon M. J., Atherden S. M., Levinsky R. J. Congenital adrenal hyperplasia: renin and steroid values during treatment. Eur J Pediatr. 1977 Aug 23;126(1-2):86–96. doi: 10.1007/BF00443127. [DOI] [PubMed] [Google Scholar]
  7. Horner J. M., Hintz R. L., Luetscher J. A. The role of renin and angiotensin in salt-losing, 21-hydroxylase-deficient congenital adrenal hyperplasia. J Clin Endocrinol Metab. 1979 May;48(5):776–783. doi: 10.1210/jcem-48-5-776. [DOI] [PubMed] [Google Scholar]
  8. Hughes I. A., Wilton A., Lole C. A., Gray O. P. Continuing need for mineralocorticoid therapy in salt-losing congenital adrenal hyperplasia. Arch Dis Child. 1979 May;54(5):350–355. doi: 10.1136/adc.54.5.350. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Hughes I. A., Winter J. S. The application of a serum 17OH-progesterone radioimmunoassay to the diagnosis and management of congenital adrenal hyperplasia. J Pediatr. 1976 May;88(5):766–773. doi: 10.1016/s0022-3476(76)81112-2. [DOI] [PubMed] [Google Scholar]
  10. Imai M., Igarashi Y., Sokabe H. Plasma renin activity in congenital virilizing adrenal hyperplasia. Pediatrics. 1968 May;41(5):897–904. [PubMed] [Google Scholar]
  11. Imai M., Igarashi Y., Sokabe H. Plasma renin activity in congenital virilizing adrenal hyperplasia. Pediatrics. 1968 May;41(5):897–904. [PubMed] [Google Scholar]
  12. JACOBS D. R., VAN DER POLL J., GABRILOVE J. L., SOFFER L. J. 17alpha-Hydroxyprogesterone--a salt-losing steroid: relation to congenital adrenal hyperplasia. J Clin Endocrinol Metab. 1961 Aug;21:909–922. doi: 10.1210/jcem-21-8-909. [DOI] [PubMed] [Google Scholar]
  13. LANDAU R. L., LUGIBIHL K. Inhibition of the sodium-retaining influence of aldosterone by progesterone. J Clin Endocrinol Metab. 1958 Nov;18(11):1237–1245. doi: 10.1210/jcem-18-11-1237. [DOI] [PubMed] [Google Scholar]
  14. Schaison G., Couzinet B., Gourmelen M., Elkik F., Bougneres P. Angiotensin and adrenal steroidogenesis: study of 21-hydroxylase-deficient congenital adrenal hyperplasia. J Clin Endocrinol Metab. 1980 Dec;51(6):1390–1394. doi: 10.1210/jcem-51-6-1390. [DOI] [PubMed] [Google Scholar]
  15. Strickland A. L., Kotchen T. A. A study of the renin-aldosterone system in congenital adrenal hyperplasia. J Pediatr. 1972 Nov;81(5):962–969. doi: 10.1016/s0022-3476(72)80550-x. [DOI] [PubMed] [Google Scholar]
  16. WILKINS L., LEWIS R. A., KLEIN R., ROSEMBERG E. The suppression of androgen secretion by cortisone in a case of congenital adrenal hyperplasia. Bull Johns Hopkins Hosp. 1950 Apr;86(4):249–252. [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood are provided here courtesy of BMJ Publishing Group

RESOURCES